Showing results (1131-1140 of 1,155) with videos related to

Sort By:
Pageof 116
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2023
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter TrialEmma Sophia Zwanenburg, Charlotte El Klaver, Daniel D Wisselink, et al.
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
Blood|April 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemiaPhilipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, et al.
BMC Cancer|May 25, 2015
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trialCharlotte E L Klaver, Gijsbert D Musters, Willem A Bemelman, et al.
The Lancet. Gastroenterology & Hepatology|August 16, 2024
Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trialRobin A Faber, Ruben P J Meijer, Daphne H M Droogh, et al.
BMC Cancer|September 6, 2022
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)K van den Berg, D P Schaap, E L K Voogt, et al.
BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.
The Lancet. Oncology|June 29, 2026
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trialKoen P Rovers, Checca Bakkers, Teun B M van den Heuvel, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
BMC Surgery|July 25, 2020
Perineal wound closure using gluteal turnover flap or primary closure after abdominoperineal resection for rectal cancer: study protocol of a randomised controlled multicentre trial (BIOPEX-2 study)Sarah Sharabiany, Robin D Blok, Oren Lapid, et al.
Pageof 116